Collaborative Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$235K Sell
256
-521
-67% -$528K 0.11% 131
2025
Q4
$835K Buy
777
+271
+54% +$259K 0.29% 74
2025
Q3
$386K Sell
506
-4
-0.8% -$2.98K 0.16% 124
2025
Q2
$398K Buy
510
+8
+2% +$6.22K 0.17% 114
2025
Q1
$415K Buy
502
+17
+4% +$14.1K 0.19% 104
2024
Q4
$374K Buy
485
+10
+2% +$8.28K 0.17% 114
2024
Q3
$421K Buy
475
+14
+3% +$12.6K 0.19% 106
2024
Q2
$417K Hold
461
0.2% 102
2024
Q1
$359K Sell
461
-5
-1% -$3.56K 0.18% 110
2023
Q4
$272K Buy
+466
New +$272K 0.15% 126

Other funds holding LLY

Collaborative Wealth Management's LLY Position: Q1 2026 in Review

Collaborative Wealth Management reduced its Eli Lilly (LLY) stake by 67% in Q1 2026, selling an estimated $528K and leaving 256 shares worth $235K. The position accounts for 0.11% of the portfolio, ranked #131.

Collaborative Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $835K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Collaborative Wealth Management held 256 shares of Eli Lilly worth $235K as of Q1 2026.
  • Collaborative Wealth Management sold 521 Eli Lilly shares in Q1 2026, an estimated $528K.
  • Eli Lilly made up 0.11% of Collaborative Wealth Management's portfolio in Q1 2026, its #131 holding.
  • Collaborative Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Collaborative Wealth Management's Eli Lilly position peaked at $835K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Collaborative Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.